IQVIA Expands Veeva Partnership with Enterprise-Wide Clinical Operations Suite
Event summary
- IQVIA has selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standards for its clinical development studies.
- This expands the existing partnership between IQVIA and Veeva, which previously included EDC solutions.
- The integration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making in clinical research.
- IQVIA will offer all Veeva clinical solutions to sponsors, enabling a full Veeva technology stack.
- The announcement was made on October 13, 2026.
The big picture
This expansion solidifies IQVIA's position as a leader in clinical research services by leveraging Veeva's specialized software suite. The move aligns with the broader industry trend of digitizing and streamlining clinical trials to reduce timelines and costs. With over 94,000 employees and a global footprint, IQVIA's adoption of Veeva's solutions could set a new standard for clinical operations in the life sciences sector.
What we're watching
- Integration Success
- How seamlessly IQVIA and Veeva can integrate their technologies to deliver on promised efficiencies.
- Market Adoption
- The pace at which sponsors adopt the combined IQVIA-Veeva technology stack for clinical trials.
- Competitive Response
- Whether competitors like Oracle Health Sciences or Medidata will respond with similar partnerships or innovations.
Related topics
